Literature DB >> 110337

C3 activation by monosodium urate monohydrate and other crystalline material.

P Hasselbacher.   

Abstract

Monosodium urate monohydrate (MSUM) is a potent activator of the complement system as measured by electrophoretic conversion of beta1C to beta1A. Activation of C3 in human serum by MSUM is both time- and dose-dependent. The sensitivity of the assay allows detection of C3 activation by as little as 0.2 mg/ml of MSUM. It was observed that C3 activation is calcium dependent and elimination by both EDTA and EGTA, a finding that demonstrated the major role of the classic pathway of complement activation. Excess calcium or magnesium alone inhibited C3 activation by MSUM in accord with the inhibitory effect of these cations on sensitized sheep cell hemolysis by complement. Heating of MSUM at 200 degrees C for 2 hours removes the water of crystallization such that heated crystals may no longer be considered MSUM. Such treatment has a variable effect on C3 activation. Of the crystals and other material studied, only zymosan was more potent than MSUM in activating C3. Calcium prophosphate dihydrate and hydroxyapatite activated significant amounts of C3. Asbestos, glass wool, or a variety of microcrystalline steroids activated little or no C3.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110337     DOI: 10.1002/art.1780220603

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Can hydroxyapatite deposition in the eye cause a neutrophil-related inflammatory reaction?

Authors:  N Klaassen-Broekema; K E Veldkamp; O P Van Bijsterveld
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

2.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.

Authors:  Chun-Jen Chen; Yan Shi; Arron Hearn; Kate Fitzgerald; Douglas Golenbock; George Reed; Shizuo Akira; Kenneth L Rock
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

3.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 4.  Intra-articular apatite crystal deposition.

Authors:  H R Schumacher; P V Cherian; A J Reginato; T Bardin; S Rothfuss
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 5.  Crystals and inflammation.

Authors:  P Platt; W C Dick
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Chemotactic factor generation by asbestos. Fibre type differences and the effects of leaching.

Authors:  E Yano; A Takeuch; Y Yukiyamo; R C Brown
Journal:  Br J Exp Pathol       Date:  1984-04

7.  Remodeling of large bone defects in the treatment of space-occupying lesions. Curettage without bone graft for treating benign bone tumors.

Authors:  M Chigira; H Watanabe; S Arita; K Noda; T Shimizu; T Shinozaki; M Nagase
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

8.  Granules are necessary for death of neutrophils after phagocytosis of crystalline monosodium urate.

Authors:  A M Rich; K N Giedd; P Cristello; G Weissmann
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

9.  Crystal deposition in the knee and great toe joints of asymptomatic gout patients.

Authors:  T D Kennedy; C S Higgens; D F Woodrow; J T Scott
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

Review 10.  Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.

Authors:  George Nuki
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.